Hospira Recalls Magnesium Sulfate Injection Due to Particulate Matter
Hospira Inc. is recalling specific lots of Magnesium Sulfate Injection due to confirmed particulate matter. The recall covers 88,500 vials distributed in the US and several Middle Eastern countries.
- Product
- Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.
- Category
- Drug
- Distribution
- Distributed nationwide